1. Continuous amnioinfusion for treatment of mid-trimester preterm premature rupture of membranes with oligoamnios
- Author
-
Misako Hideshima, Satoko Tsuda, Makoto Nomiyama, Kunio So, Takeshi Ono, Masatoshi Yokoyama, Atsushi Kawaguchi, Izumi Kawasaki, Masazumi Ikeda, and Keisuke Tsumura
- Subjects
Adult ,medicine.medical_specialty ,Fetal Membranes, Premature Rupture ,medicine.medical_treatment ,Oligohydramnios ,Gestational Age ,Gestation period ,Amnioinfusion ,Pregnancy ,medicine ,Mid trimester ,Humans ,Infusions, Parenteral ,Amniotic fluid index ,Amnion ,Retrospective Studies ,business.industry ,Obstetrics ,Pregnancy Outcome ,Obstetrics and Gynecology ,medicine.disease ,Amniotic Fluid ,Delivery, Obstetric ,Prognosis ,Treatment Outcome ,Gestation ,Female ,Pregnancy Trimesters ,business ,Premature rupture of membranes - Abstract
AIM Given the scarcity of relevant reports, this study aimed to elucidate whether pregnancy can be prolonged by maintaining the amniotic fluid volume with continuous transabdominal amnioinfusion (TA) for patients with mid-trimester preterm premature rupture of membranes (PPROM) and oligoamnios. METHODS We retrospectively examined patients who were managed during hospitalization at our department after developing PPROM between week 22 day 0 and week 25 day 6 of gestation and subsequent oligoamnios (amniotic fluid index [AFI]
- Published
- 2019